# Unmasking Cryoglobulinemia: A Cold-Blooded Complication of Hepatitis C

**Authors:** Alexandra M. Arges, Ari Levine

PMC · DOI: 10.1155/crhe/8382433 · Case Reports in Hepatology · 2025-07-24

## TL;DR

A man with hepatitis C developed cryoglobulinemia, an autoimmune condition, and improved after treatment, though some symptoms persisted.

## Contribution

This case highlights HCV's role in mixed cryoglobulinemia and the effectiveness of antiviral therapy in managing the condition.

## Key findings

- The patient's symptoms resolved after antiviral treatment for HCV.
- Mixed cryoglobulinemia was confirmed through positive cryoglobulin testing.
- Neuropathy persisted despite treatment, indicating possible long-term effects.

## Abstract

A 43-year-old man presents to the hospital with two weeks of persistent fevers, accompanied by myalgias, hematochezia, and abdominal pain. Acute infectious causes were ruled out, and elevated inflammatory markers suggested inflammatory diarrhea or autoimmune conditions. Esophagogastroduodenoscopy (EGD) and colonoscopy were negative. Further testing showed positive antinuclear antibodies (ANAs), ribonucleoprotein (RNP), rheumatoid factor (RF), and hepatitis C virus (HCV) RNA, suggesting an HCV-associated autoimmune process. Hematuria and neuropathic pain raised suspicion for mixed cryoglobulinemia secondary to HCV, supported by low complement levels. Treatment started with prednisone. Cryoglobulins came back positive, confirming mixed cryoglobulinemia secondary to HCV. The patient was referred to the hepatology clinic for antiviral treatment, where he completed treatment, with symptoms resolving, except for his neuropathy.

## Linked entities

- **Diseases:** mixed cryoglobulinemia (MONDO:0007407), neuropathy (MONDO:0005244)

## Full-text entities

- **Genes:** CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, SLC17A5 (solute carrier family 17 member 5) [NCBI Gene 26503] {aka AST, ISSD, NSD, SD, SIALIN, SIASD}
- **Diseases:** types II and III (MESH:C536044), infectious (MESH:D003141), hematochezia (MESH:D006471), infections (MESH:D007239), -Blooded (MESH:D006402), inflammatory (MESH:D007249), renal failure (MESH:D051437), viral hepatitides (MESH:D006525), Cryoglobulinemia (MESH:D003449), edema (MESH:D004487), arthralgias (MESH:D018771), Peripheral cryoglobulin (MESH:D010523), febrile illness (MESH:D005334), hepatitis infection (MESH:D056486), Renal involvement (MESH:C565423), GI involvement (MESH:C564676), mucosa (MESH:D018442), cardiovascular disease (MESH:D002318), B-cell lymphoma (MESH:D016393), inflammatory bowel disease (MESH:D015212), cough (MESH:D003371), petechial rash (MESH:D005076), polyp (MESH:D011127), myalgias (MESH:D063806), neuropathic pain (MESH:D009437), Hepatitis C (MESH:D019698), Mixed cryoglobulinemia (MESH:C565141), chest pain (MESH:D002637), type 2 diabetes (MESH:D003924), gastrointestinal symptoms (MESH:D012817), active (OMIM:612348), erosions (MESH:D014077), pleural effusion (MESH:D010996), glomerulonephritis (MESH:D005921), acute hepatitis C (MESH:D017114), shortness of breath (MESH:D004417), hypothyroidism (MESH:D007037), purpura (MESH:D011693), bleeding (MESH:D006470), neuropathy (MESH:D009422), acute (MESH:D000208), nephritic syndrome (MESH:D013577), gastrointestinal (MESH:D005767), hypertensive (MESH:D006973), fatigue (MESH:D005221), diarrhea (MESH:D003967), Hematuria (MESH:D006417), mixed cryoglobulinemic vasculitis (MESH:D014657), lymphadenopathy (MESH:D008206), abdominal pain (MESH:D015746), autoimmune conditions (MESH:D001327), headache (MESH:D006261), febrile (MESH:D000071072)
- **Chemicals:** steroids (MESH:D013256), Mavyret (MESH:C000654128), alcohol (MESH:D000438), rituximab (MESH:D000069283), glecaprevir (MESH:C000612853), pibrentasvir (MESH:C000622691), prednisone (MESH:D011241), gabapentin (MESH:D000077206)
- **Species:** Nicotiana tabacum (American tobacco, species) [taxon 4097], HCV [taxon 11103], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12313380/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12313380/full.md

## References

6 references — full list in the complete paper: https://tomesphere.com/paper/PMC12313380/full.md

---
Source: https://tomesphere.com/paper/PMC12313380